Antonio López-Beltrán

27.0k total citations · 2 hit papers
537 papers, 16.5k citations indexed

About

Antonio López-Beltrán is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Antonio López-Beltrán has authored 537 papers receiving a total of 16.5k indexed citations (citations by other indexed papers that have themselves been cited), including 276 papers in Surgery, 250 papers in Pulmonary and Respiratory Medicine and 132 papers in Molecular Biology. Recurrent topics in Antonio López-Beltrán's work include Bladder and Urothelial Cancer Treatments (214 papers), Urinary and Genital Oncology Studies (170 papers) and Prostate Cancer Treatment and Research (112 papers). Antonio López-Beltrán is often cited by papers focused on Bladder and Urothelial Cancer Treatments (214 papers), Urinary and Genital Oncology Studies (170 papers) and Prostate Cancer Treatment and Research (112 papers). Antonio López-Beltrán collaborates with scholars based in Spain, United States and Italy. Antonio López-Beltrán's co-authors include Rodolfo Montironi, Liang Cheng, Marina Scarpelli, Gregory T. MacLennan, Ziya Kırkalı, John N. Eble, Francesco Massari, Roberta Mazzucchelli, David G. Bostwick and Shaobo Zhang and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Antonio López-Beltrán

527 papers receiving 16.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2004 WHO Classification of the Renal Tumors of the Adults

2006 655 citations Antonio López-Beltrán, Marina Scarpelli et al. profile →
Understanding Pathologic Variants of Renal Cell Carcinoma: Distilling Therapeutic Opportunities from Biologic Complexity

2014 393 citations John N. Eble, Antonio López-Beltrán et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Antonio López-Beltrán Spain	63	7.7k	7.0k	5.6k	3.5k	2.7k	537	16.5k
Éva Compérat France	59	15.0k 1.9×	6.0k 0.9×	4.2k 0.7×	3.9k 1.1×	2.1k 0.8×	367	20.8k
George J. Netto United States	65	5.2k 0.7×	7.4k 1.1×	7.5k 1.3×	4.6k 1.3×	3.5k 1.3×	390	17.6k
John N. Eble United States	69	4.8k 0.6×	10.5k 1.5×	9.4k 1.7×	2.8k 0.8×	3.9k 1.5×	290	17.2k
David J. Grignon United States	76	4.9k 0.6×	14.6k 2.1×	6.0k 1.1×	3.5k 1.0×	3.7k 1.4×	364	20.8k
Arndt Hartmann Germany	76	6.4k 0.8×	4.9k 0.7×	8.7k 1.5×	6.0k 1.7×	4.5k 1.7×	715	21.0k
John C. Cheville United States	82	7.9k 1.0×	16.6k 2.4×	12.5k 2.2×	7.5k 2.1×	5.1k 1.9×	511	27.6k
Ferrán Algaba Spain	44	5.4k 0.7×	4.2k 0.6×	3.4k 0.6×	1.6k 0.5×	1.4k 0.5×	190	9.8k
Mitchell C. Benson United States	52	3.1k 0.4×	8.6k 1.2×	3.9k 0.7×	2.8k 0.8×	2.2k 0.8×	268	13.3k
Ganesh V. Raj United States	53	3.2k 0.4×	5.8k 0.8×	4.0k 0.7×	2.2k 0.6×	1.8k 0.7×	195	11.5k
Brett Delahunt New Zealand	54	3.0k 0.4×	10.8k 1.5×	5.9k 1.0×	1.9k 0.5×	3.0k 1.1×	300	14.2k

Countries citing papers authored by Antonio López-Beltrán

Since Specialization

Citations

This map shows the geographic impact of Antonio López-Beltrán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio López-Beltrán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio López-Beltrán more than expected).

Fields of papers citing papers by Antonio López-Beltrán

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio López-Beltrán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio López-Beltrán. The network helps show where Antonio López-Beltrán may publish in the future.

Co-authorship network of co-authors of Antonio López-Beltrán

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio López-Beltrán. A scholar is included among the top collaborators of Antonio López-Beltrán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio López-Beltrán. Antonio López-Beltrán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fonseca, Jorge, Maria Francisca Moraes‐Fontes, Celso Matos, et al.. (2023). Retzius-sparing robot-assisted radical prostatectomy in a medium size oncological center holds adequate oncological and functional outcomes. Journal of Robotic Surgery. 17(3). 1133–1142. 2 indexed citations

Santiago, Inês, João Santinha, Andrada Ianuș, et al.. (2019). Susceptibility Perturbation MRI Maps Tumor Infiltration into Mesorectal Lymph Nodes. Cancer Research. 79(9). 2435–2444. 5 indexed citations

Cimadamore, Alessia, Marina Scarpelli, Maria Rosaria Raspollini, et al.. (2019). Prostate cancer pathology: What has changed in the last 5 years. Urologia Journal. 87(1). 3–10. 9 indexed citations

Santoni, Matteo, Francesco Massari, Vincenzo Di Nunno, et al.. (2018). Immunotherapy in renal cell carcinoma: latest evidence and clinical implications. PMC. 1 indexed citations

Carrozza, Francesco, Matteo Santoni, Francesco Piva, et al.. (2018). Emerging immunotherapeutic strategies targeting telomerases in genitourinary tumors. Critical Reviews in Oncology/Hematology. 131. 1–6. 8 indexed citations

López-Beltrán, Antonio, Rodolfo Montironi, Shaobo Zhang, et al.. (2018). Inherited Forms of Bladder Cancer: A review of Lynch Syndrome and Other Inherited Conditions. 3 indexed citations

Giulietti, Matteo, Matteo Santoni, Alessia Cimadamore, et al.. (2018). Exploring Small Extracellular Vesicles for Precision Medicine in Prostate Cancer. Frontiers in Oncology. 8. 221–221. 20 indexed citations

Cimadamore, Alessia, Roberta Mazzucchelli, Liang Cheng, et al.. (2017). Long Non-coding RNAs in Prostate Cancer with Emphasis on Second Chromosome Locus Associated with Prostate-1 Expression. PMC. 1 indexed citations

Izquierdo, Laura, Mercedes Ingelmo‐Torres, Carme Mallofré, et al.. (2017). Prognostic microRNAs in upper tract urothelial carcinoma: multicenter and international validation study. Oncotarget. 8(31). 51522–51529. 9 indexed citations

10.

Kouba, Erik, Shaoxiong Chen, Sean R. Williamson, et al.. (2016). Solitary fibrous tumour of the genitourinary tract: a clinicopathological study of 11 cases and their association with the NAB2 - STAT6 fusion gene. Journal of Clinical Pathology. 70(6). 508–514. 19 indexed citations

11.

Mazzucchelli, Roberta, Andrea Benedetto Galosi, Matteo Santoni, et al.. (2015). Role of the pathologist in active surveillance for prostate cancer.. PubMed. 37(1). 65–8. 2 indexed citations

12.

Santoni, Matteo, Alessandro Conti, Francesco Piva, et al.. (2015). Role of STAT3 pathway in genitourinary tumors. PMC. 1 indexed citations

13.

López-Beltrán, Antonio, Matteo Santoni, Francesco Massari, et al.. (2015). Bladder Cancer: Molecular Determinants of Personalized Therapy. Current Drug Targets. 16(2). 115–124. 13 indexed citations

14.

Grau, Laura, Noreli Franco, Esteban Orenes‐Piñero, et al.. (2011). Multiplexed Methylation Profiles of Tumor Suppressor Genes in Bladder Cancer. Journal of Molecular Diagnostics. 13(1). 29–40. 38 indexed citations

15.

Cebrián, Virginia, Virginia López, Esteban Orenes‐Piñero, et al.. (2008). Identification of PMF1 Methylation in Association with Bladder Cancer Progression. Clinical Cancer Research. 14(24). 8236–8243. 29 indexed citations

16.

Wang, Xiaoyan, Timothy D. Jones, Shaobo Zhang, et al.. (2006). Amplifications of EGFR gene and protein expression of EGFR, Her-2/neu, c-kit, and androgen receptor in phyllodes tumor of the prostate. Modern Pathology. 20(2). 175–182. 20 indexed citations

17.

Montironi, Rodolfo, Remigio Vela Navarrete, Antonio López-Beltrán, et al.. (2006). Histopathology reporting of prostate needle biopsies. 2005 update. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 449(1). 1–13. 15 indexed citations

18.

López-Beltrán, Antonio. (2003). Spanish Levantine rock art. Oxford Art Online. 1 indexed citations

19.

Pacelli, Anna, Antonio López-Beltrán, Michael Egan, & David G. Bostwick. (1998). Prostatic adenocarcinoma with glomeruloid features. Human Pathology. 29(5). 543–546. 24 indexed citations

20.

López-Beltrán, Antonio, et al.. (1996). Human papillomavirus DNA as a factor determining the survival of bladder cancer patients. British Journal of Cancer. 73(1). 124–127. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact